Melanoma Clinician Resources

For decades, doctors and researchers have conducted clinical trials to further progress in the clinical implementation of tumor immunotherapy. Former President Jimmy Carter’s success with immunotherapy for advanced melanoma and Vice President Joe Biden’s Cancer Moonshot Initiative have brought this new treatment type, as well as cancer treatments in general, into the spotlight for the general public. As a result, health care professionals may experience a spike in inquiries about this new treatment.

Several immunotherapy agents are now available for melanoma. Although surgery often remains the first line of treatment, especially for early-stage melanomas, the U.S. Food and Drug Administration (FDA) is rapidly approving new immunotherapy medications for advanced melanoma.

Learn more about melanoma and how immunotherapy is changing the treatment landscape in the following pages:

Melanoma_Professional_Resource_Guide_cover.jpg

This content courtesy of Immunotherapy for the Treatment of Melanoma for Health Care Professionals.

Click to download the full PDF.

Discussions

  • I would like to participate as well ------------------------------ Enrique Arenas Lahuerta PhD Postdoctoral Fellow Vall D'Hebron Institute of Oncology ------------------------------

  • Hi Priya, I know that you posted this a while back, just wondering if you still needed any more writers? Thanks, Insiya ------------------------------ Insiya Jafferji PhD Sr. Research Scientist ...

  • Surgical Oncology/Cancer Immunotherapy Research Fellowships are available at the National Cancer Institute (NCI) of the National Institutes of Health (NIH) under the leadership of Dr. Steven ...

  • Hi Todd, We would love to have your chapter but the deadline for book chapters has passed. However, if you can get your contribution by October 25, 2021, we should be able to review it ...

Resources

Oct 22, 2021 3:50 PM
On October 13, 2021, leading experts from the SITC Immune Effector Cell-related Adverse Events Guideline Expert Panel presented the "SITC Clinical Practice Guideline Webinar – Case Studies in Immune Effector Cell-related Adverse Events." This high-level webinar covered advanced concepts of toxicity management ...
Oct 7, 2021 1:20 PM
On October 6, 2021, leading experts from the SITC Immune Checkpoint Inhibitor-related Adverse Events Guideline Expert Panel presented the "SITC Clinical Practice Guideline Webinar – Case Studies in Immune Checkpoint Inhibitor-related Adverse Events." This high-level webinar covered advanced concepts ...
Sep 20, 2021 1:08 PM
On September 16, 2021, leading experts from the SITC Immune Checkpoint Inhibitor-related Adverse Events Guideline Expert Panel presented the "SITC Clinical Practice Guideline Webinar – Practical Management Pearls for Immune Checkpoint Inhibitor-related Adverse Events." This high-level webinar covered ...
Aug 26, 2021 4:37 PM
On August 25, 2021, leading experts in cancer immunotherapy presented an overview of the publication "Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of urothelial cancer" during a live webinar. The recorded webinar and presentation slides ...